Rationale: Patient participation in medical decision-making is widely advocated, but outcomes are inconsistent.
The Institute of Medicine (1), the Affordable Care Act (2), the U.S. Preventive Services Task Force (3) , and the Centers for Medicare & Medicaid Services (CMS) (4) have all called for increased patient participation in medical decision-making to improve health care quality. The majority of patients have role preferences for treatment decisions (5) , and increasingly patients desire active involvement (6) . Unfortunately, few patients participate in medical decision-making (7) (8) (9) , and discordance between patients' preferred and actual roles is common (10, 11) . The importance of patient participation in medical decision-making has been associated with measures of adherence, trust, satisfaction with physicians, satisfaction with care, and/or satisfaction with the decisions; however, results across studies are inconsistent (12) .
Shared decision-making is a collaborative approach whereby clinicians and the patient take into account the best available evidence as well as the patient's values and preferences to make medical decisions together. Shared decision-making improves patient knowledge in some clinical contexts, but evidence is mixed regarding its effectiveness to improve patient satisfaction or other important health outcomes (13) (14) (15) . Among patients with lung and colorectal cancer, physiciancontrolled decision-making for cancer treatment was associated with lower odds of excellent patient-reported quality, regardless of patients' preferred role (16) . Actual decision-making role was not associated with accurate knowledge about the benefits of chemotherapy among patients with incurable cancers (17) . Role concordance (agreement between patients' preferred and actual roles) in patients with breast cancer was associated with more satisfaction with cancer treatment choices (18) . Research examining patient participation in cancer treatment decisions is considerable, whereas patients' roles in cancer screening decisions are less well studied.
Lung cancer screening is the first adopter of CMS-mandated shared decisionmaking as part of the initial clinical encounter. The U.S. Preventive Services Task Force envisioned that this process would provide an opportunity for patients and providers to discuss the potential benefits, harms, and uncertainties of screening while potentially minimizing unintended consequences (19) . The vast majority of positive lung cancer screening results involve the detection of pulmonary nodules (20) . Given the emphasis on patient participation in decision-making and uncertainty regarding its impact in lung cancer screening, we sought to explore the association between decision-making and patients' perceptions of care and knowledge while undergoing longitudinal incidental pulmonary nodule surveillance. The decisional pathways and unintended consequences in nodule surveillance are similar to those of lung cancer screening. Because widespread implementation of patient participation in decision-making is advocated, it is essential to develop a better understanding of its potential impact. We sought to determine the associations between decision-making and patients' perceptions of their care and knowledge while undergoing pulmonary nodule surveillance.
Methods

Setting and Participants
We conducted a prospective, repeatedmeasures cohort study at the Veterans Affairs Portland Health Care System, an academically affiliated hospital network with outlying primary care clinics. The study was conducted from February 2012 through July 2016 with patients with an incidentally detected (i.e., not from lung cancer screening) pulmonary nodule. Patients' imaging is electronically flagged, and primary care providers are responsible for notifying patients and determining the follow-up plan within this hospital network. Eligible study participants had a newly reported nodule smaller than 3 cm, had not yet obtained follow-up imaging, and were approved for participation by their primary care provider. Participants had study visits after each encounter in which nodule surveillance activities (i.e., imaging or biopsy) were planned or every 6 months if no new surveillance activity was planned, with a maximum of five study visits. The Veterans Affairs Portland Health Care System Internal Review Board approved this study (approval no. 2630), and all participants provided written informed consent. These methods have been described previously (21) .
Exposure
The primary exposure was concordance between patients' preferred and actual decision-making roles regarding initial and longitudinal pulmonary nodule surveillance activities. Preferred and actual decision-making roles were assessed for each encounter using the Control Preferences Scale (CPS) (22) . The CPS has been used extensively in decision-making research and measures the control preferences construct, defined as "the degree of control an individual wants to assume when decisions are being made about medical treatment." 22 Roles are measured with a 5-point Likert scale, with items ranging from the individual making the treatment decisions ("patientcontrolled"), to the individual making the decisions jointly with the physician ("shared"), to the physician making the decisions ("provider-controlled"). Participants were asked how they wanted the decision to be made ("preferred decision-making role") and how the final decision actually was made ("actual decision-making role") for each decisionmaking encounter. The CPS is an easily administered, valid, and reliable measure of roles in health care decision-making (11, 23, 24) , which is clinically relevant across a variety of patient populations and clinical contexts (10, 25, 26) .
Outcomes
Patient-reported outcomes included perceptions of care and knowledge. Three different perceptions of care were included: 1. Satisfaction with medical care was measured with a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree) as participants responded to the statement, "I am very satisfied with the medical care I receive." 2. Quality of medical care was measured with a 0-to 10-point Likert scale (0 = worst to 10 = best) as participants responded to the question, "How would you rate the overall quality of the medical care you are receiving from this provider?" 3. Perception of whether care could be better was measured with a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree) as participants responded to the statement, "There are some things about the medical care I receive that could be better."
To assess knowledge of their pulmonary nodules, participants were asked the following two questions:
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1. At all encounters, they were asked, "What is your likelihood of having lung cancer?" (0-100% by decile). A similar scale for lung cancer risk has been used previously (27) . 2. At the initial encounter only, they were asked, "How informed are you about what a pulmonary nodule is?" (0-to 10-point Likert scale with 0 = worst and 10 = best).
Statistical Analysis
Decision-making role was categorized by encounter according to concordance between participants' preferred and actual roles. Role concordance was defined as exact agreement between participants' preferred and actual decision-making roles. Three categories of decision-making were stratified (patient controlled, shared, or provider controlled) on the basis of the CPS (11, 21) . Additional analyses dichotomized actual decision-making as shared or not shared (patient or provider controlled), by encounter. Outcome variables were dichotomized by median split for analysis: quality of medical care as 0-9 or 10, and satisfaction with medical care and perception that care could be better as at least disagree or at least agree. Patient-reported lung cancer risk was dichotomized by median split per previous analyses as less than or equal to 30% and greater than 30%, and pulmonary nodule information was dichotomized as 0-3 (low) and 4-10 (high) (21, 28) . Exchangeable generalized estimating equations (GEEs) were used to model the within-subject covariance across encounters (29, 30) . GEEs are often used to analyze longitudinal and other correlated response data, particularly if responses are binary. Models were adjusted by relevant baseline characteristics selected a priori and included age, sex, race/ ethnicity, education, marital status, income, smoking history, and employment status. Exchangeable GEE models were also used to assess trends in decision-making roles (active or passive) and role concordance over time across encounters. Active roles were defined as shared or patient controlled, and passive role was defined as provider controlled. Models were adjusted by the same covariates as the main models. We conducted sensitivity analyses that considered outcome variables as continuous for initial encounters. The findings were similar to those in the primary analysis. All analyses were performed using Stata version 14 (StataCorp LP, College Station, TX), and two-sided statistical significance was defined as a resultant P value less than 0.05.
Results
This study included 121 participants and 319 decision-making encounters. The mean follow-up time for nodule surveillance was 18 months (SD 6 8 mo). Among participants at the first encounter, the mean age was 64 years, 93% of patients were male, 87% were white, 64% had at least some college or vocational school, 47% were former smokers, and the mean number of encounters was 2.3 (SD 6 1.3). Among participants, 45% reported a greater than 30% estimated lung cancer risk, and 57% reported they were not very informed about their nodules (0-3 points) on a 10-point scale (Table 1) . According to the Mayo Clinic pulmonary nodule clinical prediction model (31), the mean lung cancer risk was 10% (SD 6 12 %), and it was less than 30% for 95% of participants at the first encounter.
Participant characteristics are presented for the entire cohort and stratified by role concordance, if decision-making roles were always concordant or discordant for at least one encounter (Table 1) . Two participants did not answer role questions, and 13 were missing an actual decision-making role for all encounters. Demographics and preferred roles, when available, were similar among participants with and without missing data. Participants expressed a preferred role in decisionmaking for more than 98% of encounters (314 of 319). The preferred role in decision-making was shared for 56% (176 of 314), provider controlled for 24% (76 of 314), and patient controlled for 20% (62 of 314). Five encounters were missing both (preferred and actual) decisionmaking roles, and 116 were missing an actual decision-making role only. Among the 116 encounters missing an actual decision-making role, many participants did not know what their role was and/or that a 22 ; P = 0.94) nor their actual (Adj-OR, 1.08; 95% CI, 0.84-1.38; P = 0.57) decisionmaking role was significantly different across encounters over time. Role concordance increased over the first four encounters; however, the trend was not significant across all encounters (Adj-OR, 1.13; 95% CI, 0.89-1.45; P = 0.31) (Figure 1) .
Encounters with role concordance were associated with greater satisfaction with medical care (Adj-OR, 5.39, 95% CI, 1.68-17.26; P = 0.005) and higher patientreported quality of medical care (Adj-OR, 2.86; 95% CI, 1.31-6.27; P = 0.009). After encounters with role concordance, patients were more likely to disagree that medical care could be better (Adj-OR, 2.16; 95% CI, 1.12-4.16; P = 0.02) ( Table 3) . Role concordance was not associated with more accurate pulmonary nodule knowledge with respect to lung cancer risk at encounter 1 (Adj-OR, 0.28; 95% CI, 0.06-1.31; P = 0.11) or at all encounters (Adj-OR, 1.10; 95% CI, 0.62-1.97; P = 0.74), or regarding patient-reported nodule information at encounter 1 (Adj-OR, 1.14; 95% CI, 0.31-4.13; P = 0.85) ( Table 4) .
In terms of actual decision-making role, patient-reported shared decisionmaking occurred in 26% (51 of 198) of encounters. Encounters that included shared decision-making were not associated with satisfaction with medical care (Adj-OR, 3.36; 95% CI, 0.74-15.24; P = 0.12), patient-reported quality of medical care (Adj-OR, 0.86; 95% CI, 0.35-2.11; P = 0.73), or perception that care could be better (Adj-OR, 1.58; 95% CI, 0.73-3.41; P = 0.24). Shared decision-making was not associated with pulmonary nodule knowledge with respect to lung cancer risk at encounter 1 (Adj-OR, 1.12; 95% CI, 0.14-9.10; P = 0.91) or at all encounters (Adj-OR, 1.58; 95% CI, 0.72-3.43; P = 0.25) or regarding patient-reported nodule information at encounter 1 (Adj-OR, 4.05; 95% CI, 0.58-28.34; P = 0.16).
Discussion
Among patients undergoing longitudinal pulmonary nodule surveillance, we found that patients overwhelmingly had decisionmaking role preferences and that most wanted an active role. Interestingly, during some encounters, patients did not know what their actual decision-making role was and/or that a decision was being made. Role concordance occurred only about half the time, and when roles were discordant, the patient usually had a more passive role than they desired. Role concordance was associated with greater satisfaction with medical care, patientreported higher quality of care, and more disagreement that care could be better. Role concordance was not associated with improved patient perceptions of nodule knowledge. Patient-reported shared decision-making occurred in a minority of encounters and was not associated with perceptions of medical care or knowledge.
Since the term patient-centered care was first coined in 1988 (32) , there has been an increasing trend (6) toward incorporating patients' values and preferences in medical decision-making. However, significant variability exists in patients' desire for participation (33, 34) . Among U.S. adults, the vast majority (96%) want to be asked their opinion and to 
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be offered choices by their clinicians; however, an almost equal proportion favor physician-controlled and patient-controlled decisions (35) . Patients' perceived role can influence their desire to participate because patients who perceive less involvement in decision-making have subsequent preferences for passive decision-making (26) . Additionally, patients' preferences for participation can be influenced by demographic factors, diagnosis, health status, types of decisions, amount of knowledge they possess about their condition, and interactions with their clinicians (36) . For a sizable number of encounters, patients did not know what their actual role in the decision-making process was, even though in the majority of these encounters patients had a preferred role. In some of these encounters, patients reported that they were not aware that a medical decision was actually being made. These results are not entirely surprising, because in a national sample of U.S. adults, for five of six nonsurgical medical decisions, a majority of respondents did not think they were asked their opinion (8) . Among patients with cancer (37) and neurological conditions (38) , 30% and 72%, respectively, reported being given treatment choices. This is the first study, to our knowledge, to assess decision-making roles and outcomes in pulmonary nodule surveillance or lung cancer screening. The circumstances surrounding encounters where patients were unaware of their actual role in decision-making deserve more exploration; however, they likely represent a concerning breakdown of communication in the decision-making process. Patient preferences and role concordance may be especially important in scenarios where clinical equipoise exists, such as lung cancer screening. Lung cancer screening can trigger a cascade of serious and stressful interventions (39) (40) (41) , and different pathways can entail various combinations of therapeutic and adverse effects. Therefore, patients' preferences should play a major role in decisionmaking. Patients have demonstrated a willingness to undergo lung cancer screening, and the CMS has mandated patient participation in decision-making (42) . However, few studies have demonstrated a willingness of patients to actively participate in the decision-making process or have included examinations of associated outcomes.
Shared decision-making is associated with improved treatment adherence (43) and affective-cognitive outcomes (13) such as patient satisfaction and decisional conflict. However, evidence is lacking for associations with improved health outcomes (13) , and results of randomized controlled trials have been mixed (44) . In the setting of pulmonary nodule surveillance, neither shared decisionmaking nor role concordance was associated with patient distress (27) . Although shared decision-making is currently espoused as the preferred model in decision-making, we found that role concordance and not shared decisionmaking per se was important to patients' perceptions of care.
Role concordance has been associated with reduced anxiety in patients with cancer (45) and with better physical and emotional quality of life in cancer survivors (46) . Ensuring role concordance may be a critical step in patient participation in decision-making and may be essential in building a therapeutic alliance between patients and their clinicians. Ideally, clinicians should offer patients an opportunity to participate by first sharing information, asking patients about their values, priorities, and decision-making role preferences, and then engaging in a decision-making process to determine the next diagnostic or treatment steps. The benefits of this strategy are twofold: (1) Clinicians become aware of patients' decision-making role preferences, and (2) patients have an opportunity to participate as much or as little as they prefer. Our results suggest that a shared and informed model of care that increases patients' knowledge about treatment options, benefits, and harms depends on more than role congruency or shared decision-making, as neither of these was associated with more accurate patient knowledge. Decision aids deserve more exploration in this population because they have demonstrated an ability to educate patients and provide patients an opportunity to participate in decisions that involve weighing the benefits and harms of ORIGINAL RESEARCH treatment options that have scientific uncertainty (47, 48) . Patients' preferences vary on the basis of the type of decision (49), but they do not typically change over time (11, 50, 51) . Therefore, if patients indicate an active decision-making preference at the outset, they should be afforded an opportunity to participate throughout the nodule evaluation process.
Limitations
The present study has limitations. The cohort was composed of a mainly white male population from the Pacific Northwest. Participants were consistently surveyed soon after their clinical encounters; however, survey studies are subject to recall bias. A proportion of participants did not know their actual role in decision-making; these encounters had an incomplete CPS and were therefore excluded. Incorporating an objective measure of participants' actual role in decision-making may have increased role concordance; however, patients' reliability in reporting decision-making roles has been demonstrated previously (52) . When decision-making is measured from the perspective of the patient (as opposed to observers' or clinicians' perspectives), regardless of the outcome category, assessments are more likely to result in significant associations (11) . Our results are dependent on the dichotomization of decision-making roles based on patient role concordance and do not consider alternative approaches, which is a potential limitation.
Conclusions
Among 
